MDA5 protein mediating persistent ER stress/unfolded protein response contributes to endothelial-mesenchymal-transition of lung microvascular endothelial cell in dermatomyositis

Background Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The model of anti-MDA5 antibody positive DM has been already reported. However, the detailed role and mechanism of MDA5 in vascular damage was stil...

Full description

Saved in:
Bibliographic Details
Published inCell communication and signaling Vol. 23; no. 1; pp. 149 - 17
Main Authors Zhao, Li-Qin, Yang, Xue-Qing, Niu, Qian, Feng, Xiao, Zhang, He-De, Ye, Shu-Yi, Jiang, Li-Juan, Yu, Fan, Ye, Hong, Ma, Wan-Li
Format Journal Article
LanguageEnglish
Published London BioMed Central 23.03.2025
BioMed Central Ltd
BMC
Subjects
Online AccessGet full text
ISSN1478-811X
1478-811X
DOI10.1186/s12964-025-02159-2

Cover

Abstract Background Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The model of anti-MDA5 antibody positive DM has been already reported. However, the detailed role and mechanism of MDA5 in vascular damage was still poorly understood. Methods Clinical information was retrospectively collected, and a total of 127 DM patients were enrolled. Serum from DM patients and control subjects was used to treat mouse lung microvascular endothelial cells (MVECs) to investigate vascular changes. Western blotting, quantitative real-time polymerase chain reaction (qRT-PCR), immunofluorescence staining, immunoprecipitation, protein mass spectrometry, flow cytometry and bioinformatics analysis were used. Results Firstly, clinical data analysis revealed that vascular damage and interstitial lung disease (ILD) was correlated with anti-MDA5 antibody in DM patients. Then, serum from patients was used to treat mouse lung MVECs. Serum from MDA5 + DM patients induced endothelial-mesenchymal-transition (EndMT) in MVECs, and the EndMT in MVECs was mediated by TRB3/ERK/Snai-1 pathway. Next, increased-TRB3 was confirmed induced by persistent ER stress/unfolded protein response (UPR). Notably, persistent ER stress/UPR resulted from MDA5 protein binding with PERK. At last, T cell-derived IFN-β was found to induce MDA5 expression in DM patients. Conclusion MDA5 protein mediating persistent ER stress/UPR contributed to EndMT in vascular endothelial cells, which should be involved in MDA5 + DM related ILD.
AbstractList Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The model of anti-MDA5 antibody positive DM has been already reported. However, the detailed role and mechanism of MDA5 in vascular damage was still poorly understood.BACKGROUNDDermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The model of anti-MDA5 antibody positive DM has been already reported. However, the detailed role and mechanism of MDA5 in vascular damage was still poorly understood.Clinical information was retrospectively collected, and a total of 127 DM patients were enrolled. Serum from DM patients and control subjects was used to treat mouse lung microvascular endothelial cells (MVECs) to investigate vascular changes. Western blotting, quantitative real-time polymerase chain reaction (qRT-PCR), immunofluorescence staining, immunoprecipitation, protein mass spectrometry, flow cytometry and bioinformatics analysis were used.METHODSClinical information was retrospectively collected, and a total of 127 DM patients were enrolled. Serum from DM patients and control subjects was used to treat mouse lung microvascular endothelial cells (MVECs) to investigate vascular changes. Western blotting, quantitative real-time polymerase chain reaction (qRT-PCR), immunofluorescence staining, immunoprecipitation, protein mass spectrometry, flow cytometry and bioinformatics analysis were used.Firstly, clinical data analysis revealed that vascular damage and interstitial lung disease (ILD) was correlated with anti-MDA5 antibody in DM patients. Then, serum from patients was used to treat mouse lung MVECs. Serum from MDA5 + DM patients induced endothelial-mesenchymal-transition (EndMT) in MVECs, and the EndMT in MVECs was mediated by TRB3/ERK/Snai-1 pathway. Next, increased-TRB3 was confirmed induced by persistent ER stress/unfolded protein response (UPR). Notably, persistent ER stress/UPR resulted from MDA5 protein binding with PERK. At last, T cell-derived IFN-β was found to induce MDA5 expression in DM patients.RESULTSFirstly, clinical data analysis revealed that vascular damage and interstitial lung disease (ILD) was correlated with anti-MDA5 antibody in DM patients. Then, serum from patients was used to treat mouse lung MVECs. Serum from MDA5 + DM patients induced endothelial-mesenchymal-transition (EndMT) in MVECs, and the EndMT in MVECs was mediated by TRB3/ERK/Snai-1 pathway. Next, increased-TRB3 was confirmed induced by persistent ER stress/unfolded protein response (UPR). Notably, persistent ER stress/UPR resulted from MDA5 protein binding with PERK. At last, T cell-derived IFN-β was found to induce MDA5 expression in DM patients.MDA5 protein mediating persistent ER stress/UPR contributed to EndMT in vascular endothelial cells, which should be involved in MDA5 + DM related ILD.CONCLUSIONMDA5 protein mediating persistent ER stress/UPR contributed to EndMT in vascular endothelial cells, which should be involved in MDA5 + DM related ILD.
Background Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The model of anti-MDA5 antibody positive DM has been already reported. However, the detailed role and mechanism of MDA5 in vascular damage was still poorly understood. Methods Clinical information was retrospectively collected, and a total of 127 DM patients were enrolled. Serum from DM patients and control subjects was used to treat mouse lung microvascular endothelial cells (MVECs) to investigate vascular changes. Western blotting, quantitative real-time polymerase chain reaction (qRT-PCR), immunofluorescence staining, immunoprecipitation, protein mass spectrometry, flow cytometry and bioinformatics analysis were used. Results Firstly, clinical data analysis revealed that vascular damage and interstitial lung disease (ILD) was correlated with anti-MDA5 antibody in DM patients. Then, serum from patients was used to treat mouse lung MVECs. Serum from MDA5 + DM patients induced endothelial-mesenchymal-transition (EndMT) in MVECs, and the EndMT in MVECs was mediated by TRB3/ERK/Snai-1 pathway. Next, increased-TRB3 was confirmed induced by persistent ER stress/unfolded protein response (UPR). Notably, persistent ER stress/UPR resulted from MDA5 protein binding with PERK. At last, T cell-derived IFN-β was found to induce MDA5 expression in DM patients. Conclusion MDA5 protein mediating persistent ER stress/UPR contributed to EndMT in vascular endothelial cells, which should be involved in MDA5 + DM related ILD.
Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The model of anti-MDA5 antibody positive DM has been already reported. However, the detailed role and mechanism of MDA5 in vascular damage was still poorly understood. Clinical information was retrospectively collected, and a total of 127 DM patients were enrolled. Serum from DM patients and control subjects was used to treat mouse lung microvascular endothelial cells (MVECs) to investigate vascular changes. Western blotting, quantitative real-time polymerase chain reaction (qRT-PCR), immunofluorescence staining, immunoprecipitation, protein mass spectrometry, flow cytometry and bioinformatics analysis were used. Firstly, clinical data analysis revealed that vascular damage and interstitial lung disease (ILD) was correlated with anti-MDA5 antibody in DM patients. Then, serum from patients was used to treat mouse lung MVECs. Serum from MDA5 + DM patients induced endothelial-mesenchymal-transition (EndMT) in MVECs, and the EndMT in MVECs was mediated by TRB3/ERK/Snai-1 pathway. Next, increased-TRB3 was confirmed induced by persistent ER stress/unfolded protein response (UPR). Notably, persistent ER stress/UPR resulted from MDA5 protein binding with PERK. At last, T cell-derived IFN-[beta] was found to induce MDA5 expression in DM patients. MDA5 protein mediating persistent ER stress/UPR contributed to EndMT in vascular endothelial cells, which should be involved in MDA5 + DM related ILD.
Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The model of anti-MDA5 antibody positive DM has been already reported. However, the detailed role and mechanism of MDA5 in vascular damage was still poorly understood. Clinical information was retrospectively collected, and a total of 127 DM patients were enrolled. Serum from DM patients and control subjects was used to treat mouse lung microvascular endothelial cells (MVECs) to investigate vascular changes. Western blotting, quantitative real-time polymerase chain reaction (qRT-PCR), immunofluorescence staining, immunoprecipitation, protein mass spectrometry, flow cytometry and bioinformatics analysis were used. Firstly, clinical data analysis revealed that vascular damage and interstitial lung disease (ILD) was correlated with anti-MDA5 antibody in DM patients. Then, serum from patients was used to treat mouse lung MVECs. Serum from MDA5 + DM patients induced endothelial-mesenchymal-transition (EndMT) in MVECs, and the EndMT in MVECs was mediated by TRB3/ERK/Snai-1 pathway. Next, increased-TRB3 was confirmed induced by persistent ER stress/unfolded protein response (UPR). Notably, persistent ER stress/UPR resulted from MDA5 protein binding with PERK. At last, T cell-derived IFN-β was found to induce MDA5 expression in DM patients. MDA5 protein mediating persistent ER stress/UPR contributed to EndMT in vascular endothelial cells, which should be involved in MDA5 + DM related ILD.
Background Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The model of anti-MDA5 antibody positive DM has been already reported. However, the detailed role and mechanism of MDA5 in vascular damage was still poorly understood. Methods Clinical information was retrospectively collected, and a total of 127 DM patients were enrolled. Serum from DM patients and control subjects was used to treat mouse lung microvascular endothelial cells (MVECs) to investigate vascular changes. Western blotting, quantitative real-time polymerase chain reaction (qRT-PCR), immunofluorescence staining, immunoprecipitation, protein mass spectrometry, flow cytometry and bioinformatics analysis were used. Results Firstly, clinical data analysis revealed that vascular damage and interstitial lung disease (ILD) was correlated with anti-MDA5 antibody in DM patients. Then, serum from patients was used to treat mouse lung MVECs. Serum from MDA5 + DM patients induced endothelial-mesenchymal-transition (EndMT) in MVECs, and the EndMT in MVECs was mediated by TRB3/ERK/Snai-1 pathway. Next, increased-TRB3 was confirmed induced by persistent ER stress/unfolded protein response (UPR). Notably, persistent ER stress/UPR resulted from MDA5 protein binding with PERK. At last, T cell-derived IFN-[beta] was found to induce MDA5 expression in DM patients. Conclusion MDA5 protein mediating persistent ER stress/UPR contributed to EndMT in vascular endothelial cells, which should be involved in MDA5 + DM related ILD. Keywords: MDA5, Anti-MDA5 antibody, Dermatomyositis (DM), Interstitial lung disease (ILD), Endothelial-Mesenchymal-Transition (EndMT), Endoplasmic reticulum stress (ER stress), Unfolded protein responses (UPR)
Abstract Background Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The model of anti-MDA5 antibody positive DM has been already reported. However, the detailed role and mechanism of MDA5 in vascular damage was still poorly understood. Methods Clinical information was retrospectively collected, and a total of 127 DM patients were enrolled. Serum from DM patients and control subjects was used to treat mouse lung microvascular endothelial cells (MVECs) to investigate vascular changes. Western blotting, quantitative real-time polymerase chain reaction (qRT-PCR), immunofluorescence staining, immunoprecipitation, protein mass spectrometry, flow cytometry and bioinformatics analysis were used. Results Firstly, clinical data analysis revealed that vascular damage and interstitial lung disease (ILD) was correlated with anti-MDA5 antibody in DM patients. Then, serum from patients was used to treat mouse lung MVECs. Serum from MDA5 + DM patients induced endothelial-mesenchymal-transition (EndMT) in MVECs, and the EndMT in MVECs was mediated by TRB3/ERK/Snai-1 pathway. Next, increased-TRB3 was confirmed induced by persistent ER stress/unfolded protein response (UPR). Notably, persistent ER stress/UPR resulted from MDA5 protein binding with PERK. At last, T cell-derived IFN-β was found to induce MDA5 expression in DM patients. Conclusion MDA5 protein mediating persistent ER stress/UPR contributed to EndMT in vascular endothelial cells, which should be involved in MDA5 + DM related ILD.
BackgroundDermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The model of anti-MDA5 antibody positive DM has been already reported. However, the detailed role and mechanism of MDA5 in vascular damage was still poorly understood.MethodsClinical information was retrospectively collected, and a total of 127 DM patients were enrolled. Serum from DM patients and control subjects was used to treat mouse lung microvascular endothelial cells (MVECs) to investigate vascular changes. Western blotting, quantitative real-time polymerase chain reaction (qRT-PCR), immunofluorescence staining, immunoprecipitation, protein mass spectrometry, flow cytometry and bioinformatics analysis were used.ResultsFirstly, clinical data analysis revealed that vascular damage and interstitial lung disease (ILD) was correlated with anti-MDA5 antibody in DM patients. Then, serum from patients was used to treat mouse lung MVECs. Serum from MDA5 + DM patients induced endothelial-mesenchymal-transition (EndMT) in MVECs, and the EndMT in MVECs was mediated by TRB3/ERK/Snai-1 pathway. Next, increased-TRB3 was confirmed induced by persistent ER stress/unfolded protein response (UPR). Notably, persistent ER stress/UPR resulted from MDA5 protein binding with PERK. At last, T cell-derived IFN-β was found to induce MDA5 expression in DM patients.ConclusionMDA5 protein mediating persistent ER stress/UPR contributed to EndMT in vascular endothelial cells, which should be involved in MDA5 + DM related ILD.
ArticleNumber 149
Audience Academic
Author Ma, Wan-Li
Feng, Xiao
Zhang, He-De
Zhao, Li-Qin
Ye, Hong
Ye, Shu-Yi
Yang, Xue-Qing
Jiang, Li-Juan
Yu, Fan
Niu, Qian
Author_xml – sequence: 1
  givenname: Li-Qin
  surname: Zhao
  fullname: Zhao, Li-Qin
  organization: Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
– sequence: 2
  givenname: Xue-Qing
  surname: Yang
  fullname: Yang, Xue-Qing
  organization: Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
– sequence: 3
  givenname: Qian
  surname: Niu
  fullname: Niu, Qian
  organization: Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
– sequence: 4
  givenname: Xiao
  surname: Feng
  fullname: Feng, Xiao
  organization: Department of Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
– sequence: 5
  givenname: He-De
  surname: Zhang
  fullname: Zhang, He-De
  organization: Department of Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
– sequence: 6
  givenname: Shu-Yi
  surname: Ye
  fullname: Ye, Shu-Yi
  organization: Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
– sequence: 7
  givenname: Li-Juan
  surname: Jiang
  fullname: Jiang, Li-Juan
  organization: Department of Rheumatology and Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
– sequence: 8
  givenname: Fan
  surname: Yu
  fullname: Yu, Fan
  organization: Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Key Laboratory of Respiratory Diseases, National Health Commission of China
– sequence: 9
  givenname: Hong
  surname: Ye
  fullname: Ye, Hong
  email: yehmwl@hust.edu.cn
  organization: Department of Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Key Laboratory of Respiratory Diseases, National Health Commission of China, Basic School of Medicine, Tongji Medical College, Huazhong University of Science and Technology
– sequence: 10
  givenname: Wan-Li
  surname: Ma
  fullname: Ma, Wan-Li
  email: whmawl@hust.edu.cn
  organization: Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Key Laboratory of Respiratory Diseases, National Health Commission of China, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40122798$$D View this record in MEDLINE/PubMed
BookMark eNp9k9tu1DAQhiNURA_wAlygSNzARVqfkjhXaFUKVCpCKiBxZznOJPUqsbe2U7GPxRsy2y1tFyEURbEm3_-PPZ45zPacd5BlLyk5plRWJ5GyphIFYSW-tGwK9iQ7oKKWhaT0x96j9X52GOOSECZKUT_L9gWhjNWNPMh-fX6_KPNV8AmsyyforE7WDfkKQrQxgUv52WUeU4AYT2bX-7GD7p7H6Mq7CLnxLgXbzglinnwOrvPpCkarx2KCCM5crSdcp6BdtMl6l_s-H2dMNFkT_I2OZh51eCzMDYxjjkk6CJNOflr7jTQ-z572eozw4u57lH3_cPbt9FNx8eXj-eniojAl46kwkrTQakJEYwzvdMkpo0SwXrS00xyoMZK3VHdQk0a2RtaVaXVbNYxUErTmR9n51rfzeqlWwU46rJXXVt0GfBiUDsmaERTomghBeFlqKlpRog3vGO2BdVLXkqLXu63Xam6xxgbLGvS4Y7r7x9krNfgbRWnDCaEcHd7cOQR_PUNMarJxUyHtwM9RcSpx303JCKKv_0KXfg4Oa6U4I7SsKinqB2rQeAKLN4uJzcZULSRnjNd1XSF1_A8Knw7w4rAde4vxHcHbHcGmMeBnGvQcozr_ernLvnpclfty_OlOBNgWwBaJMUB_j1CiNiOgtiOgcATU7QgohiK-FUWE3QDh4fj_Uf0GSDAMqA
Cites_doi 10.1016/j.jaad.2010.09.016
10.1038/nature04734
10.1073/pnas.2313070121
10.1136/annrheumdis-2017-212149
10.1093/rheumatology/keu289
10.1111/1346-8138.13397
10.1016/j.jaad.2020.12.032
10.1016/j.celrep.2020.108628
10.1093/rheumatology/kead117
10.1016/j.chest.2020.04.057
10.3389/fimmu.2021.773352
10.1038/s41467-020-17798-x
10.1007/s10067-015-2935-9
10.1002/art.10924
10.1016/j.cell.2012.11.048
10.3390/genes10110864
10.1111/ced.14870
10.1146/annurev-pathol-012513-104649
10.1128/MCB.01009-12
10.1001/jamaneurol.2018.2598
10.1186/s12931-021-01908-4
10.1080/03079457.2018.1556386
10.1016/j.jaad.2010.08.004
10.3390/ijms23158193
10.1128/jvi.01388-22
10.1111/cup.14203
10.1136/ard.2010.139949
10.1002/jcp.28993
10.1146/annurev-biochem-062209-093836
10.1038/ni907
10.1016/j.semarthrit.2020.11.009
10.1126/science.aac7049
10.1038/nrm3270
10.1111/febs.14608
10.1093/rheumatology/kez357
10.1038/celldisc.2016.24
10.1016/j.jaad.2019.05.105
10.1152/ajpendo.00117.2006
10.1002/advs.202401327
10.1016/j.cell.2017.12.016
10.1016/j.tim.2018.08.007
10.1136/annrheumdis-2013-203279
10.1093/rheumatology/keac525
10.1002/art.40320
ContentType Journal Article
Copyright The Author(s) 2025
2025. The Author(s).
COPYRIGHT 2025 BioMed Central Ltd.
2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2025 2025
Copyright_xml – notice: The Author(s) 2025
– notice: 2025. The Author(s).
– notice: COPYRIGHT 2025 BioMed Central Ltd.
– notice: 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2025 2025
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISR
3V.
7QP
7X7
7XB
88E
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
RC3
7X8
5PM
DOA
DOI 10.1186/s12964-025-02159-2
DatabaseName Springer Nature OA Free Journals (ODIN)
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Science
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


MEDLINE



Publicly Available Content Database
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1478-811X
EndPage 17
ExternalDocumentID oai_doaj_org_article_ea70440355a14b45ab63d21fe2d8a781
PMC11930013
A832237776
40122798
10_1186_s12964_025_02159_2
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: the National Natural Science Foundation of China
  grantid: No. 82070066 and 82270075; No. 82270111 and 81973991
– fundername: the National Natural Science Foundation of China
  grantid: No. 82270111 and 81973991
– fundername: the National Natural Science Foundation of China
  grantid: No. 82070066 and 82270075
GroupedDBID ---
0R~
29B
2WC
53G
5VS
6J9
7X7
88E
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AASML
ABDBF
ABUWG
ACGFO
ACGFS
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
E3Z
EBD
EBLON
EBS
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IGS
IHR
INH
INR
ISR
ITC
KQ8
LK8
M1P
M7P
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
TR2
TUS
UKHRP
WOQ
XSB
~8M
AAYXX
ALIPV
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7QP
7XB
8FD
8FK
AZQEC
DWQXO
FR3
GNUQQ
K9.
M48
P64
PKEHL
PQEST
PQUKI
RC3
7X8
5PM
ID FETCH-LOGICAL-c523t-c80beba0049cc3da53121042f4b1da3e1cc83b1ade7098bc876cbab692068eaa3
IEDL.DBID C6C
ISSN 1478-811X
IngestDate Wed Aug 27 01:32:51 EDT 2025
Thu Aug 21 18:40:07 EDT 2025
Fri Sep 05 05:41:44 EDT 2025
Fri Jul 25 19:29:34 EDT 2025
Tue Jun 17 21:59:04 EDT 2025
Tue Jun 10 20:59:53 EDT 2025
Fri Jun 27 05:12:55 EDT 2025
Mon Jul 21 06:02:08 EDT 2025
Tue Aug 05 12:12:14 EDT 2025
Sat Sep 06 07:22:37 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Interstitial lung disease (ILD)
Anti-MDA5 antibody
Unfolded protein responses (UPR)
Endoplasmic reticulum stress (ER stress)
Dermatomyositis (DM)
Endothelial-Mesenchymal-Transition (EndMT)
MDA5
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c523t-c80beba0049cc3da53121042f4b1da3e1cc83b1ade7098bc876cbab692068eaa3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://doi.org/10.1186/s12964-025-02159-2
PMID 40122798
PQID 3201566847
PQPubID 40257
PageCount 17
ParticipantIDs doaj_primary_oai_doaj_org_article_ea70440355a14b45ab63d21fe2d8a781
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11930013
proquest_miscellaneous_3180689520
proquest_journals_3201566847
gale_infotracmisc_A832237776
gale_infotracacademiconefile_A832237776
gale_incontextgauss_ISR_A832237776
pubmed_primary_40122798
crossref_primary_10_1186_s12964_025_02159_2
springer_journals_10_1186_s12964_025_02159_2
PublicationCentury 2000
PublicationDate 2025-03-23
PublicationDateYYYYMMDD 2025-03-23
PublicationDate_xml – month: 03
  year: 2025
  text: 2025-03-23
  day: 23
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Cell communication and signaling
PublicationTitleAbbrev Cell Commun Signal
PublicationTitleAlternate Cell Commun Signal
PublicationYear 2025
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References S Ahmad (2159_CR9) 2018; 172
T Schwartz (2159_CR49) 2014; 73
H Shakshouk (2159_CR8) 2022; 47
B Wu (2159_CR35) 2013; 152
A Lion (2159_CR13) 2019; 48
Y Kochi (2159_CR40) 2018; 77
A Meyer (2159_CR2) 2015; 54
KY Sun (2159_CR3) 2021; 51
IE Lundberg (2159_CR47) 2017; 69
RL Smith (2159_CR21) 2004; 31
X Yin (2159_CR12) 2021; 34
SA Oakes (2159_CR17) 2015; 10
CE Zhang (2159_CR41) 2016; 43
X Sun (2159_CR42) 2016; 2
R Waldman (2159_CR44) 2020; 82
D Fiorentino (2159_CR7) 2011; 65
X Lian (2159_CR46) 2023; 62
AP Liao (2159_CR37) 2011; 70
W Yu (2159_CR32) 2020; 21
A Almanza (2159_CR24) 2019; 286
A Nombel (2159_CR14) 2021; 12
RK Bode (2159_CR20) 2003; 49
X Cao (2159_CR22) 2021; 22
2159_CR4
X Lian (2159_CR5) 2020; 158
CD Scharer (2159_CR28) 2020; 11
Y Ichimura (2159_CR16) 2024; 121
W Cheng (2159_CR31) 2019; 19
SZ Yacoub Wasef (2159_CR30) 2006; 291
WK Yu (2159_CR29) 2022; 23
M Xue (2159_CR43) 2022; 96
X Chen (2159_CR45) 2024; 42
Y Abe (2159_CR25) 2020; 59
D Zheng (2159_CR33) 2024; 11
Y Liu (2159_CR36) 2023; 62
X Cao (2159_CR23) 2020; 235
K Mariampillai (2159_CR1) 2018; 75
NN Iwakoshi (2159_CR26) 2003; 4
S Zahn (2159_CR15) 2011; 64
L Li (2159_CR38) 2017; 2017
I Braakman (2159_CR18) 2011; 80
H Shakshouk (2159_CR6) 2022; 49
BJ Liddicoat (2159_CR10) 2015; 349
H Kato (2159_CR34) 2006; 441
Y Gao (2159_CR27) 2012; 32
A Wang (2159_CR48) 2021; 84
AG Dias Junior (2159_CR11) 2019; 27
C Hetz (2159_CR19) 2012; 13
J Song (2159_CR39) 2019; 10
References_xml – volume: 65
  start-page: 25
  issue: 1
  year: 2011
  ident: 2159_CR7
  publication-title: J Am Acad Dermatol
  doi: 10.1016/j.jaad.2010.09.016
– volume: 441
  start-page: 101
  issue: 7089
  year: 2006
  ident: 2159_CR34
  publication-title: Nature
  doi: 10.1038/nature04734
– volume: 121
  start-page: e2313070121
  issue: 16
  year: 2024
  ident: 2159_CR16
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.2313070121
– volume: 77
  start-page: 602
  issue: 4
  year: 2018
  ident: 2159_CR40
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2017-212149
– volume: 31
  start-page: 1644
  issue: 8
  year: 2004
  ident: 2159_CR21
  publication-title: J Rheumatol
– volume: 54
  start-page: 50
  issue: 1
  year: 2015
  ident: 2159_CR2
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/keu289
– volume: 43
  start-page: 1307
  issue: 11
  year: 2016
  ident: 2159_CR41
  publication-title: J Dermatol
  doi: 10.1111/1346-8138.13397
– volume: 19
  start-page: 2869
  issue: 4
  year: 2019
  ident: 2159_CR31
  publication-title: Mol Med Rep
– volume: 84
  start-page: 1610
  issue: 6
  year: 2021
  ident: 2159_CR48
  publication-title: J Am Acad Dermatol
  doi: 10.1016/j.jaad.2020.12.032
– volume: 34
  start-page: 108628
  issue: 2
  year: 2021
  ident: 2159_CR12
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2020.108628
– volume: 62
  start-page: 3724
  issue: 11
  year: 2023
  ident: 2159_CR36
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kead117
– volume: 158
  start-page: 1535
  issue: 4
  year: 2020
  ident: 2159_CR5
  publication-title: Chest
  doi: 10.1016/j.chest.2020.04.057
– volume: 21
  start-page: 615
  issue: 2
  year: 2020
  ident: 2159_CR32
  publication-title: Mol Med Rep
– volume: 12
  start-page: 773352
  year: 2021
  ident: 2159_CR14
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.773352
– volume: 11
  start-page: 3989
  issue: 1
  year: 2020
  ident: 2159_CR28
  publication-title: Nat Commun
  doi: 10.1038/s41467-020-17798-x
– ident: 2159_CR4
  doi: 10.1007/s10067-015-2935-9
– volume: 49
  start-page: 7
  issue: 1
  year: 2003
  ident: 2159_CR20
  publication-title: Arthritis Rheum
  doi: 10.1002/art.10924
– volume: 152
  start-page: 276
  issue: 1–2
  year: 2013
  ident: 2159_CR35
  publication-title: Cell
  doi: 10.1016/j.cell.2012.11.048
– volume: 10
  start-page: 864
  issue: 11
  year: 2019
  ident: 2159_CR39
  publication-title: Genes (Basel)
  doi: 10.3390/genes10110864
– volume: 47
  start-page: 282
  issue: 2
  year: 2022
  ident: 2159_CR8
  publication-title: Clin Exp Dermatol
  doi: 10.1111/ced.14870
– volume: 10
  start-page: 173
  year: 2015
  ident: 2159_CR17
  publication-title: Annu Rev Pathol
  doi: 10.1146/annurev-pathol-012513-104649
– volume: 32
  start-page: 5129
  issue: 24
  year: 2012
  ident: 2159_CR27
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.01009-12
– volume: 75
  start-page: 1528
  issue: 12
  year: 2018
  ident: 2159_CR1
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2018.2598
– volume: 22
  start-page: 312
  issue: 1
  year: 2021
  ident: 2159_CR22
  publication-title: Respir Res
  doi: 10.1186/s12931-021-01908-4
– volume: 48
  start-page: 121
  issue: 2
  year: 2019
  ident: 2159_CR13
  publication-title: Avian Pathol
  doi: 10.1080/03079457.2018.1556386
– volume: 64
  start-page: 988
  issue: 5
  year: 2011
  ident: 2159_CR15
  publication-title: J Am Acad Dermatol
  doi: 10.1016/j.jaad.2010.08.004
– volume: 23
  start-page: 8193
  issue: 15
  year: 2022
  ident: 2159_CR29
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms23158193
– volume: 42
  start-page: 386
  issue: 2
  year: 2024
  ident: 2159_CR45
  publication-title: Clin Exp Rheumatol
– volume: 96
  start-page: e0138822
  issue: 24
  year: 2022
  ident: 2159_CR43
  publication-title: J Virol
  doi: 10.1128/jvi.01388-22
– volume: 49
  start-page: 442
  issue: 5
  year: 2022
  ident: 2159_CR6
  publication-title: J Cutan Pathol
  doi: 10.1111/cup.14203
– volume: 70
  start-page: 831
  issue: 5
  year: 2011
  ident: 2159_CR37
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2010.139949
– volume: 235
  start-page: 538
  issue: 1
  year: 2020
  ident: 2159_CR23
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.28993
– volume: 80
  start-page: 71
  issue: 1
  year: 2011
  ident: 2159_CR18
  publication-title: Annu Rev Biochem
  doi: 10.1146/annurev-biochem-062209-093836
– volume: 4
  start-page: 321
  issue: 4
  year: 2003
  ident: 2159_CR26
  publication-title: Nat Immunol
  doi: 10.1038/ni907
– volume: 51
  start-page: 175
  issue: 1
  year: 2021
  ident: 2159_CR3
  publication-title: Semin Arthritis Rheum
  doi: 10.1016/j.semarthrit.2020.11.009
– volume: 349
  start-page: 1115
  issue: 6252
  year: 2015
  ident: 2159_CR10
  publication-title: Science
  doi: 10.1126/science.aac7049
– volume: 13
  start-page: 89
  issue: 2
  year: 2012
  ident: 2159_CR19
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm3270
– volume: 286
  start-page: 241
  issue: 2
  year: 2019
  ident: 2159_CR24
  publication-title: FEBS J
  doi: 10.1111/febs.14608
– volume: 59
  start-page: 767
  issue: 4
  year: 2020
  ident: 2159_CR25
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kez357
– volume: 2
  start-page: 16024
  year: 2016
  ident: 2159_CR42
  publication-title: Cell Discov
  doi: 10.1038/celldisc.2016.24
– volume: 82
  start-page: 283
  issue: 2
  year: 2020
  ident: 2159_CR44
  publication-title: J Am Acad Dermatol
  doi: 10.1016/j.jaad.2019.05.105
– volume: 291
  start-page: E1274
  issue: 6
  year: 2006
  ident: 2159_CR30
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00117.2006
– volume: 11
  start-page: e2401327
  issue: 28
  year: 2024
  ident: 2159_CR33
  publication-title: Adv Sci (Weinh)
  doi: 10.1002/advs.202401327
– volume: 172
  start-page: 797
  issue: 4
  year: 2018
  ident: 2159_CR9
  publication-title: Cell
  doi: 10.1016/j.cell.2017.12.016
– volume: 27
  start-page: 75
  issue: 1
  year: 2019
  ident: 2159_CR11
  publication-title: Trends Microbiol
  doi: 10.1016/j.tim.2018.08.007
– volume: 73
  start-page: 1805
  issue: 10
  year: 2014
  ident: 2159_CR49
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2013-203279
– volume: 62
  start-page: 1910
  issue: 5
  year: 2023
  ident: 2159_CR46
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/keac525
– volume: 69
  start-page: 2271
  issue: 12
  year: 2017
  ident: 2159_CR47
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.40320
– volume: 2017
  start-page: 2905987
  year: 2017
  ident: 2159_CR38
  publication-title: Biomed Res Int
SSID ssj0024547
Score 2.374247
Snippet Background Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The...
Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The model of...
Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The model of...
Background Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The...
BackgroundDermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The...
Abstract Background Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 149
SubjectTerms Adult
Animals
Anti-MDA5 antibody
Antibodies
Apoptosis
B cells
Bioinformatics
Biomedical and Life Sciences
Biopsy
Blood circulation disorders
Cell Biology
Cell differentiation
Complications and side effects
Cytokines and Growth Factors
Dermatomyositis
Dermatomyositis (DM)
Dermatomyositis - metabolism
Dermatomyositis - pathology
Development and progression
Disease
Endoplasmic reticulum
Endoplasmic Reticulum Stress
Endoplasmic reticulum stress (ER stress)
Endothelial cells
Endothelial Cells - metabolism
Endothelial Cells - pathology
Endothelial-Mesenchymal-Transition (EndMT)
Endothelium
Enzymes
Epithelial cells
Epithelial-Mesenchymal Transition
Female
Flow cytometry
Health aspects
Homeostasis
Humans
Immunofluorescence
Immunoprecipitation
Interferon-Induced Helicase, IFIH1 - metabolism
Interstitial lung disease (ILD)
Kinases
Life Sciences
Lung - blood supply
Lung - pathology
Lung diseases
Lung diseases, Interstitial
Lymphocytes T
Male
Mass spectrometry
Mass spectroscopy
MDA5
Medical research
Mice
Microvasculature
Microvessels - pathology
Middle Aged
Myopathy
Patients
Pattern recognition receptors
Phosphorylation
Polymerase chain reaction
Protein binding
Protein folding
Protein-Ligand Interactions
Proteins
Receptors
Risk factors
Skin
Stem cells
T cells
Transcription factors
Vascular endothelium
Viral antibodies
Western blotting
β-Interferon
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQJSQuiG8CBRmExAGsJnYcO8cFWhWkcihU6s1ybIdW2k2qJnvYn8U_ZMZJlk0R4sItWk-UZObZ41m_mSHkjfBp6bmzDACiWS7qipWlEqyWzme5dYAiTBQ--Vocn-VfzuX5Tqsv5IQN5YEHxR0Eq7ArMrhFm-VVLm1VCM-zOnCvrYpJ1zwt0ymYmqrsyVxNKTK6OOgyPF1k2LoVfVzJ-MwNxWr9f67JO07pJmHyxqlpdEZH98jdcRdJF8Pb3ye3QvOA3B76Sm4ekp8nnxaSxhIMlw2NySHIbqZX-OcYmLXp6eEpHdJEDtYAsaUPfit_PdBmA400duyHFTratzQ0HtO1loBYtsKkJXexWcF1j-4uMr9oW9MlrB50hTS_ieS6eyPFgwIKD_HoEfp2tYmkse4ROTs6_P7xmI29GZiD0LVnTqdVqCwGGM4Jb2EqQ_CY8zqvMm9FyJzTosqsDyotdeVg0XUV2K7kaaGDteIx2WvaJjwlVMm8clJbLhxshqTWFos0OlkWTrnCy4S8m0xlroYSHCaGLrowg2ENGNZEwxqekA9oza0kls-OPwCozAgq8y9QJeQ1YsFggYwGGTg_7LrrzOdvp2aBS6BQShUJeTsK1S1o2tkxoQG-CmtqzST3Z5Iwg918eIKcGVeQzgiOSe4FbB4S8mo7jHciK64J7RpkMg3aLCVPE_JkQOj2u3M8M1WlToieYXemmPlIc3kR64tnsKnH0CAh7yeY_36vv2v-2f_Q_HNyh8dpKhgX-2Svv16HF7Dt66uXcYb_Ahi0V0E
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgCIkXxPcCAxmExANYa-wkdp5QgU0DaTwMJvXNcmxnm9QmpUkf-mfxH3LnJO0yBG9VfFFj35fP_t0dIW-Fm-SOW8NAQBRLRFmwPJeClal1cWIsSBEmCp9-z07Ok2-zdNYfuDU9rHKwicFQu9riGfmh4Jj0m4Ex_bj8xbBrFN6u9i00bpM7oXQZyLOc7QIuLFY1JMqo7LCJ8Y6RYQNX9HQ54yNnFGr2_22Zr7mmm7DJG3enwSUdPyD3-70knXbMf0hu-eoRudt1l9w8Jr9Pv0xTGgoxXFU0pIggxpku8YgMmFu19OiMdskih2sQtLnzbku_6sCzngYwO3bF8g1ta-orh0lbc5BbtsDUJXu5WcDvFp1ewH_RuqRzsCF0gWC_Aep6_UWK1wUU_sShX2jrxSZAx5on5Pz46OfnE9Z3aGAWAtiWWTUpfGEwzLBWOAMKDSFkwsukiJ0RPrZWiSI2zstJrgoLptcWpshyPsmUN0Y8JXtVXfl9QmWaFDZVhgsLW6JUKYOlGm2aZ1bazKUReT-wSi-7Qhw6BDAq0x1jNTBWB8ZqHpFPyM0tJRbRDg_q1YXudVJ7I7HhNuy4TJwUSQofJhyPS8-dMlLFEXmDsqCxTEaFOJwLs24a_fXHmZ6iIRRSyiwi73qisoaVtqZPa4BZYWWtEeXBiBL02I6HB5HTvR1p9E7qI_J6O4xvIjau8vUaaGIFq5mnfBKRZ52Ebued4M2pzFVE1Eh2RwszHqmuLkOVcVAogQFCRD4MYr77rn-v_PP_T-MFuceDAgrGxQHZa1dr_xK2dW3xKujuH0BDTy0
  priority: 102
  providerName: ProQuest
Title MDA5 protein mediating persistent ER stress/unfolded protein response contributes to endothelial-mesenchymal-transition of lung microvascular endothelial cell in dermatomyositis
URI https://link.springer.com/article/10.1186/s12964-025-02159-2
https://www.ncbi.nlm.nih.gov/pubmed/40122798
https://www.proquest.com/docview/3201566847
https://www.proquest.com/docview/3180689520
https://pubmed.ncbi.nlm.nih.gov/PMC11930013
https://doaj.org/article/ea70440355a14b45ab63d21fe2d8a781
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1Nb9Mw1IJNSFwQ3wRGZRASB4hWx3HsHNvRaSBtQoVJFRfLsR02qU2mNT30Z_EPec9Ju2bAgUsV1c9K4ved90XIO-6GuUusiYFAVJzysojzXPK4FNax1FigIiwUPj3LTs7TLzMx69rkYC3MbvyeqexwyTAuGOPQVdROeQzidl8wnoXAbHZ001dPpHJTFPPXfT3FE_rz_ymFd9TQ7RTJW3HSoH6OH5IHnd1IRy2iH5E7vnpM7rWTJNdPyK_TTyNBQ9OFy4qGchDMZ6ZX-DkMEFk1dDKlbWHI4QqIau6828Jft4mynobEdZyA5Ze0qamvHBZozYFG4wWWKdmL9QKuG1RwIdeL1iWdg7ygC0zs26S17m6kGBqgcBOHOqCpF-uQJrZ8Ss6PJ9-PTuJuGkNswVltYquGhS8MuhTWcmeAecFdTJMyLZgz3DNrFS-YcV4Oc1VYELO2MEWWJ8NMeWP4M7JX1ZV_QagUaWGFMgm3YP4IpQy2ZbQiz6y0mRMR-bBBlb5qm27o4KyoTLeI1YBYHRCrk4iMEZtbSGyYHf4AOtId_2lvJA7XBuvKsLRIBTwYdwkrfeKUkYpF5C3SgsaWGBXm3Pw0q-VSf_421SMUelxKmUXkfQdU1nDS1nQlDPBW2EWrB3nQgwSetf3lDcnpTmYsNU-wrD0DcyEib7bLuBPz4CpfrwCGKTjNXCTDiDxvKXT73ilGSWWuIqJ6tNs7mP5KdXkROoozMOPRGYjIxw2Z3zzXv0_-5f-BvyL3k8CQPE74Adlrrlf-NZh0TTEgd-VMDsj-eHL2dToInD0In0fgdzr-8Ru9sUyS
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGJgQviG8CAwwC8QDRGjsfzgNCHeu0sbVCZZP2Zhzb3SatyWhSof5TSPyH3DlJtwzB296q5tLGvp_vfPHv7gh5w00vNUwrHwAi_JBPMj9NE-5PIm2CUGlAESYKD0fxzmH45Sg6WiG_2lwYpFW2NtEZalNofEe-wRkm_cZgTD-d__CxaxSerrYtNGpY7NnFTwjZyo-7W6Dft4xtDw4-7_hNVwFfQ9BV-Vr0Mpsp3BprzY0CEELYE7JJmAVGcRtoLXgWKGOTXioyDeZCZyqLU9aLhVWKw-_eIGshZrSukrXNwejr-KK6XxQmbWqOiDfKAE81fWwZi7419VnH_bkuAX_7gkvO8CpR88pprXOC23fJnWb3Svs13O6RFZvfJzfrfpaLB-T3cKsfUVf64TSnLikFWdX0HF_KAZzyig7GtE5P2ZgDtM-MNUv5WU3XtdTR57EPly1pVVCbG0wTO4OV4k8xWUqfLKbwuUI36xhntJjQM7BadIr0wpZce_lGigcUFP7EoCeqiunCkdXKh-TwWrT3iKzmRW6fEJpEYaYjoRjXsAmLhFBYHFJHaawTHZvII-9bVcnzuvSHdCGTiGWtWAmKlU6xknlkE7W5lMSy3e6LYnYsGysgrUqwxTfs8VQQZmEED8YNCyaWGaESEXjkNWJBYmGOHJk_x2pelnL321j20fTyJElij7xrhCYFzLRWTSIFjApreXUk1zuSYDl093ILOdlYrlJerDOPvFpexjuRjZfbYg4ygYDZTCPW88jjGqHLcYd4VpukwiOig93OxHSv5Kcnrq55AMEEhiQe-dDC_OK5_j3zT_8_jJfk1s7BcF_u7472npHbzC1G7jO-Tlar2dw-h01llb1oVjIl36_bePwBuCuOyg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Nb9MwFLfQEIgL4pvAAIOQOEDUJnZi51i2VRuwCQ0m7WY5trNNapOqSQ_9s_gPec9JumbAgVtUPyux36f7fu-ZkPfMjjMbGx2CgMiQsyIPs0ywsEiMjbg2IEVYKHx8kh6e8S_nyflWFb9Hu_cpybamAbs0lc1oYYtWxWU6qiPMFoZ4FSv6rCwEI3ybo-vDdG26d91tL-GiL5X567yBO_Jd-_-0zVvO6SZw8kb21Dul6QNyv4sm6aRl_0Nyy5WPyJ32fsn1Y_LreH-SUN-K4aqkvkgEUc50gX-S1bheenBK23KR0QpEbWad3dAvW_isox7OjvdiuZo2FXWlxbKtGUhuOMfiJXO5nsNzg27PI8BoVdAZWBE6R7hfD3bdnkgxYUDhJRY9Q1PN1x48Vj8hZ9ODn3uHYXdHQ2jgCNuERo5zl2s8aBjDrAaVhkMkjwueR1YzFxkjWR5p68Q4k7kB42tynadZPE6l05o9JTtlVbrnhIqE5yaROmYGgqJESo3NGk2SpUaY1CYB-dizSi3aVhzKH2FkqlrGKmCs8oxVcUA-Izc3lNhG2_9QLS9Up5XKaYFXbkPMpSOe8wQ-jNk4KlxspRYyCsg7lAWFjTJKROJc6FVdq6Mfp2qCppAJIdKAfOiIigp22uiusAFWhb21BpS7A0rQZDMc7kVOdZakVizGYvcUgoiAvN0M40xEx5WuWgFNJGE3syQeB-RZK6GbdXPMnYpMBkQOZHewMcOR8urS9xmPILjHI0JAPvVifv1d_975F_9H_obc_b4_Vd-OTr6-JPdir5ssjNku2WmWK_cKYr4mf-3V-jf0aFNB
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MDA5+protein+mediating+persistent+ER+stress%2Funfolded+protein+response+contributes+to+endothelial-mesenchymal-transition+of+lung+microvascular+endothelial+cell+in+dermatomyositis&rft.jtitle=Cell+communication+and+signaling&rft.au=Zhao%2C+Li-Qin&rft.au=Yang%2C+Xue-Qing&rft.au=Niu%2C+Qian&rft.au=Feng%2C+Xiao&rft.date=2025-03-23&rft.pub=BioMed+Central+Ltd&rft.issn=1478-811X&rft.eissn=1478-811X&rft.volume=23&rft.issue=1&rft_id=info:doi/10.1186%2Fs12964-025-02159-2&rft.externalDocID=A832237776
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-811X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-811X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-811X&client=summon